This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Suntory Holdings Limited. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kizugawa, JP (2017)
- Kyoto, JP (2022)
Company Filing History:
Years Active: 2017-2022
Title: Innovations by Toshihide Suzuki
Introduction
Toshihide Suzuki is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compositions that enhance biological safety and health benefits. With a total of 2 patents, his work focuses on innovative solutions for health-related issues.
Latest Patents
One of his latest patents is a composition containing a cyclic dipeptide and a sweetening agent. This composition is designed to enhance the GLP-1 secretion-accelerating effect due to the sweetening agent, while maintaining excellent biological safety. The specific content ratio of the cyclic dipeptide or its salt and the sweetening agent is carefully controlled to optimize the desired effects. Another significant patent is a uric acid-lowering agent that includes a tyrosine-containing cyclic dipeptide. This agent is effective in lowering uric acid levels and is useful in the prevention or treatment of conditions such as hyperuricemia and gout.
Career Highlights
Toshihide Suzuki is currently associated with Suntory Holdings Limited, a prominent company known for its contributions to the beverage and health industries. His work at Suntory has allowed him to focus on innovative research and development in health-related products.
Collaborations
He has collaborated with notable coworkers, including Natsumi Hiraki and Shinya Fukizawa, to further advance his research and innovations.
Conclusion
Toshihide Suzuki's contributions to the field of biochemistry through his patents reflect his commitment to enhancing health and well-being. His innovative approaches continue to pave the way for advancements in health-related compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
